Cargill, Incorporated, Zoetis Inc. and Merck & Co., Inc–Considerable Market Players in Animal Health Market
Animal health is maintained by the various pharmaceutical and non-pharmaceutical products. The preventive measure can be taken by the early diagnostics and giving vaccines to prevent diseases.Factors such as of zoonotic diseases, rise in demand for proteinaceous food are majorly contributing to the growth of animal health market.
The most notable market participants are Merck & Co., Inc, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Cargill, Incorporated, Zoetis Inc., Bayer AG, Vetoquinol SA, Nutreco N.V, Virbac, and Elancooccupying a considerable share of the market owing to their offerings to the market.
The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Whereas, the inorganic strategies such as mergers & acquisitions, partnership, collaborations, were widely seen in the animal health market. Majority of the market leaders are involved in inorganic activities such as partnerships and acquisitions in order to improve their performance and consolidate market position.
These strategies are helping major players to strengthen their market positions along with widening their geographic footprints.Few of the important key developments from the industry are mentioned below:
|
Month & Year |
News |
Region |
|
February, 2020 |
Zoetis Inc announced acquisition of the Diagnostic Science, a veterinary reference lab business. The acquisition has enabled the company to strengthen its service portfolio. |
North America |
|
February, 2020 |
Vetoquinol SA announced the acquisition of Profender and Drontal product families from Elanco Animal Health. It will also acquire intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business. |
North America |
|
October, 2019 |
Boehringer Ingelheim announced a partnership with the CatCareforLife program. The program was set in April 2018 by the International Society of Feline Medicine (ISFM), the veterinary division of the UK-based charity International Cat Care (ICC). |
North America |
|
November, 2019 |
Cargill, Incorporatedhas expanded its Animal Nutrition & Health facility in Temple, Texas. It invested US$ Mn to build the manufacturing, packaging, warehousing, and shipping capabilities center. The facility centers will serve Cargill’s farm and ranch feed store owners and beef feed, customers. It will serve through reduced transportation costs for local customers and also, it has increased manufacturing capabilities. |
North America |
|
September, 2018 |
Boehringer Ingelheim International GmbHhas launched Semintra 10 mg/ml Oral Solution, to treat feline hypertension in cats. The medicine will available in selected European countries |
Europe |
|
April 2018 |
Zoetis Inc has announced the expansion of manufacturing and supply and research and development center in Suzhou, China. The new facility will for the development and production of quality vaccines for swine, cattle, fish and companion animals that will help in protecting against the strains of diseases prevalent in China. |
Asia Pacific |
|
May, 2017 |
Ceva Santé Animale has announced that the European Medicines Agency has granted it to market new products, Zeleris. The new product combines a powerful antibiotic, florfenicol, with a long-acting non-steroidal anti-inflammatory, meloxicam. |
Europe |
|
March 2017 |
Merck announced the acquisition of Vallée S.A. (Vallée), a leading privately-held producer of animal health products in Brazil. |
South and Central America |
